Posted on August 19, 20228/19/22
Case Study: Leveraging machine learning models in patient identification and behavior prediction for rare disease indications
Posted on June 1, 20226/1/22
New Medicines, New Access, New Frontiers
Posted on April 20, 20224/20/22
Navigating the Complexities of Patient Care with Digital and Human Touchpoints
Posted on March 24, 20223/24/22
New Legislation Supports Payment for Digital Therapeutics
Posted on March 11, 20223/11/22
Gene Therapy in Today’s Digital World
Posted on January 26, 20221/26/22
Reversing the Complexity of Oncology Commercialization: How to solve for launch challenges in a chaotic ecosystem
Posted on January 14, 20221/14/22
A Partnership Q&A with EVERSANA and Shorla Pharma
Posted on January 11, 20221/11/22
A YEAR OF ACTION: Why Data-Backed, Integrated Commercialization Strategies Are Must-haves in 2022
Posted on December 28, 202112/28/21
The Power to Know When: Balancing High-Tech and High-Touch Solutions to Eliminate Access, Affordability and Adherence Barriers
Posted on November 1, 202111/1/21